Where Surgery Partners Stands With Analysts
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 7 analysts have published their opinion on Surgery Partners (NASDAQ:SGRY) stock, with an average 12-month price target of $46.71, up 13.93% from the previous average of $41.00. The company has received 5 bullish and 2 somewhat bullish ratings.
June 02, 2023 | 2:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Surgery Partners has an average 12-month price target of $46.71, up 13.93% from the previous average, with 5 bullish and 2 somewhat bullish ratings from 7 analysts.
The average 12-month price target for Surgery Partners has increased by 13.93% over the past 3 months, indicating a positive outlook from analysts. With 5 bullish and 2 somewhat bullish ratings, the stock is likely to experience an upward trend in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100